KLRD1 and neoplasm: Supporting this, high KLRD1 expression correlates with increased activity of key immune components, including cytotoxic T cells, tumor-infiltrating lymphocytes, and inflammatory T cells, potentially enhancing the efficacy of immunotherapy.